FDA Accepts New Drug Application for Merck's HIV Treatment, Doravirine/Islatravir
This investigational two-drug regimen for treatment of
adults with virologically suppressed HIV was given a Prescription Drug
User Fee Act (PDUFA) ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.